X4 Pharmaceuticals, Inc Quarterly Cost of Revenue in USD from Q2 2023 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary: X4 Pharmaceuticals, Inc quarterly Cost of Revenue history and growth rate from Q2 2023 to Q2 2024.
X4 Pharmaceuticals, Inc Cost of Revenue for the quarter ending June 30, 2024 was $268K.

Cost of Revenue, Quarterly (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024		$268K	+$268K		Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-08
Q2 2023		$0			Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.